• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

急性呼吸窘迫综合征的持久影响。

The long-lasting effects of the acute respiratory distress syndrome.

机构信息

Division of Allergy, Pulmonary, and Critical Care Medicine, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.

Department of Pathology, Microbiology and Immunology, Vanderbilt University Medical Center, Nashville, TN, USA.

出版信息

Expert Rev Respir Med. 2020 Jun;14(6):577-586. doi: 10.1080/17476348.2020.1743182. Epub 2020 Mar 17.

DOI:10.1080/17476348.2020.1743182
PMID:32168460
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7454121/
Abstract

: Acute respiratory distress syndrome (ARDS) is a severe form of acute lung injury common in critically ill patients and characterized by significant morbidity and mortality. It frequently manifests long-lasting effects beyond hospitalization, from cognitive impairment to physical weakness.: Several complications of ARDS have been identified in patients after hospital discharge. The authors conducted literature searches to identify observational studies, randomized clinical trials, systematic reviews, and guidelines. A summary of is presented here to outline the sequelae of ARDS and their risk factors with a focus on the limited but growing research into possible therapies. Long term sequelae of ARDS commonly identified in the literature include long-term cognitive impairment, psychological morbidities, neuromuscular weakness, pulmonary dysfunction, and ongoing healthcare utilization with reduced quality of life.: Given the public health significance of long-term complications following ARDS, the development of new therapies for prevention and treatment is of vital importance. Furthering knowledge of the pathophysiology of these impairments will provide a framework to develop new therapeutic targets to fuel future clinical trials in this area of critical care medicine.

摘要

急性呼吸窘迫综合征(ARDS)是一种严重的急性肺损伤,常见于重症患者,其特点是发病率和死亡率高。它经常在住院后产生持久的影响,从认知障碍到身体虚弱。

在出院后,患者出现了几种 ARDS 并发症。作者进行了文献检索,以确定观察性研究、随机临床试验、系统评价和指南。这里概述了 ARDS 的后遗症及其危险因素,重点介绍了对可能治疗方法的有限但不断增加的研究。文献中常见的 ARDS 长期后遗症包括长期认知障碍、心理病态、神经肌肉无力、肺功能障碍以及持续的医疗保健利用,生活质量降低。

鉴于 ARDS 后长期并发症的公共卫生意义,开发预防和治疗这些并发症的新疗法至关重要。深入了解这些损伤的病理生理学将为开发新的治疗靶点提供框架,以推动该重症监护医学领域的未来临床试验。

相似文献

1
The long-lasting effects of the acute respiratory distress syndrome.急性呼吸窘迫综合征的持久影响。
Expert Rev Respir Med. 2020 Jun;14(6):577-586. doi: 10.1080/17476348.2020.1743182. Epub 2020 Mar 17.
2
Can we optimize long-term outcomes in acute respiratory distress syndrome by targeting normoxemia?通过靶向正常氧血症,我们能否优化急性呼吸窘迫综合征的长期结局?
Ann Am Thorac Soc. 2014 May;11(4):613-8. doi: 10.1513/AnnalsATS.201401-001PS.
3
Acute Respiratory Distress Syndrome: Etiology, Pathogenesis, and Summary on Management.急性呼吸窘迫综合征:病因、发病机制及治疗概述。
J Intensive Care Med. 2020 Aug;35(8):723-737. doi: 10.1177/0885066619855021. Epub 2019 Jun 17.
4
Improving management of ARDS: uniting acute management and long-term recovery.改善急性呼吸窘迫综合征管理:统一急性管理与长期康复。
Crit Care. 2024 Feb 23;28(1):58. doi: 10.1186/s13054-024-04810-9.
5
Pharmacotherapy for prevention and treatment of acute respiratory distress syndrome: current and experimental approaches.急性呼吸窘迫综合征的预防和治疗的药物治疗:当前和实验方法。
Drugs. 2010 Jul 9;70(10):1255-82. doi: 10.2165/10898570-000000000-00000.
6
Acute Respiratory Distress Syndrome: Diagnosis and Management.急性呼吸窘迫综合征:诊断与管理。
Am Fam Physician. 2020 Jun 15;101(12):730-738.
7
What is the clinical significance of pulmonary hypertension in acute respiratory distress syndrome? A review.肺动脉高压在急性呼吸窘迫综合征中的临床意义是什么?一篇综述。
Minerva Anestesiol. 2014 May;80(5):574-85. Epub 2013 Oct 31.
8
Emerging drugs for treating the acute respiratory distress syndrome.治疗急性呼吸窘迫综合征的新兴药物。
Expert Opin Emerg Drugs. 2019 Mar;24(1):29-41. doi: 10.1080/14728214.2019.1591369. Epub 2019 Mar 18.
9
The fibroproliferative response in acute respiratory distress syndrome: mechanisms and clinical significance.急性呼吸窘迫综合征中的纤维增生反应:机制和临床意义。
Eur Respir J. 2014 Jan;43(1):276-85. doi: 10.1183/09031936.00196412. Epub 2013 Mar 21.
10
Therapeutic iloprost for the treatment of acute respiratory distress syndrome (ARDS) (the ThIlo trial): a prospective, randomized, multicenter phase II study.治疗性伊洛前列素治疗急性呼吸窘迫综合征(ARDS)(ThIlo 试验):一项前瞻性、随机、多中心 II 期研究。
Trials. 2020 Mar 4;21(1):242. doi: 10.1186/s13063-020-4163-0.

引用本文的文献

1
Extracorporeal carbon dioxide removal for the treatment of acute hypoxaemic respiratory failure: the REST RCT.体外二氧化碳清除治疗急性低氧性呼吸衰竭:REST随机对照试验
Health Technol Assess. 2025 Jul;29(33):1-16. doi: 10.3310/GJDM0320.
2
Carbonic anhydrase IX promotes acute lung injury and mortality in females during metabolic acidosis and pneumonia.碳酸酐酶IX在代谢性酸中毒和肺炎期间会加重雌性动物的急性肺损伤并导致死亡。
Am J Physiol Lung Cell Mol Physiol. 2025 Aug 1;329(2):L266-L281. doi: 10.1152/ajplung.00331.2024. Epub 2025 Jul 7.
3
Enhanced engraftment and immunomodulatory effects of integrin alpha-2-overexpressing mesenchymal stromal cells in lipopolysaccharide-induced acute lung injury.整合素α-2过表达间充质基质细胞在脂多糖诱导的急性肺损伤中的植入增强及免疫调节作用
Stem Cell Res Ther. 2025 Jun 3;16(1):286. doi: 10.1186/s13287-025-04423-1.
4
Neurological Sequelae of Acute Hydrogen Sulfide Poisoning: A Literature Review, Controversies, and Knowledge Gaps.急性硫化氢中毒的神经后遗症:文献综述、争议与知识空白
Neurol Int. 2025 May 6;17(5):71. doi: 10.3390/neurolint17050071.
5
An interpretable machine learning model for predicting mortality risk in adult ICU patients with acute respiratory distress syndrome.一种用于预测成人急性呼吸窘迫综合征重症监护病房患者死亡风险的可解释机器学习模型。
Front Med (Lausanne). 2025 Apr 25;12:1580345. doi: 10.3389/fmed.2025.1580345. eCollection 2025.
6
Weathering the Storm: How Age and Biologics Influence the COVID-19 Cytokine Surge.经受住风暴:年龄和生物制剂如何影响COVID-19细胞因子风暴
Pathogens. 2025 Apr 3;14(4):346. doi: 10.3390/pathogens14040346.
7
Prevalence and incidence of cognitive impairment following acute respiratory distress syndrome of any cause: a systematic review and meta-analysis.任何原因引起的急性呼吸窘迫综合征后认知障碍的患病率和发病率:一项系统评价和荟萃分析
Crit Care. 2025 Apr 23;29(1):164. doi: 10.1186/s13054-025-05375-x.
8
Longitudinal recovery trajectories and ventilatory modalities in COVID-19 acute respiratory distress syndrome survivors.新冠病毒病(COVID-19)急性呼吸窘迫综合征幸存者的纵向恢复轨迹及通气模式
ERJ Open Res. 2025 Apr 7;11(2). doi: 10.1183/23120541.00770-2024. eCollection 2025 Mar.
9
Targeting mTOR in myeloid cells prevents infection-associated inflammation.靶向髓系细胞中的mTOR可预防感染相关炎症。
iScience. 2025 Mar 4;28(4):112163. doi: 10.1016/j.isci.2025.112163. eCollection 2025 Apr 18.
10
Systolic Pulmonary Artery Pressure as Long-Term Mortality Predictor in Elderly Critically Ill with Severe COVID-19 Pneumonia.收缩期肺动脉压作为老年重症新型冠状病毒肺炎患者长期死亡率的预测指标
Viruses. 2025 Feb 11;17(2):244. doi: 10.3390/v17020244.

本文引用的文献

1
Association between Adherence to Recommended Care and Outcomes for Adult Survivors of Sepsis.推荐治疗方案的依从性与成人脓毒症幸存者结局的关系。
Ann Am Thorac Soc. 2020 Jan;17(1):89-97. doi: 10.1513/AnnalsATS.201907-514OC.
2
The Association between Prehospital Vulnerability, ARDS Development, and Mortality among At-Risk Adults. Results from the LIPS-A Clinical Trial.高危成人院前脆弱性、ARDS 发生与病死率的相关性。LIPS-A 临床试验结果。
Ann Am Thorac Soc. 2019 Nov;16(11):1399-1404. doi: 10.1513/AnnalsATS.201902-116OC.
3
Randomized Clinical Trial of an ICU Recovery Pilot Program for Survivors of Critical Illness.随机临床试验 ICU 恢复期计划对危重病幸存者的影响
Crit Care Med. 2019 Oct;47(10):1337-1345. doi: 10.1097/CCM.0000000000003909.
4
Long-term neurocognitive outcome is not worsened by of the use of venovenous ECMO in severe ARDS patients.在重症急性呼吸窘迫综合征(ARDS)患者中使用静脉-静脉体外膜肺氧合(venovenous ECMO)不会使长期神经认知结局恶化。
Ann Intensive Care. 2019 Jul 16;9(1):82. doi: 10.1186/s13613-019-0556-1.
5
Long-term functional and psychological recovery in a population of acute respiratory distress syndrome patients treated with VV-ECMO and in their caregivers.VV-ECMO 治疗的急性呼吸窘迫综合征患者及其照护者的长期功能和心理康复。
Minerva Anestesiol. 2019 Sep;85(9):971-980. doi: 10.23736/S0375-9393.19.13095-7. Epub 2019 Jan 18.
6
Cognitive decline after elective and nonelective hospitalizations in older adults.老年人择期和非择期住院后的认知能力下降。
Neurology. 2019 Feb 12;92(7):e690-e699. doi: 10.1212/WNL.0000000000006918. Epub 2019 Jan 11.
7
Latent class analysis of ARDS subphenotypes: a secondary analysis of the statins for acutely injured lungs from sepsis (SAILS) study.急性呼吸窘迫综合征亚表型的潜在类别分析:脓毒症中他汀类药物治疗急性肺损伤(SAILS)研究的二次分析。
Intensive Care Med. 2018 Nov;44(11):1859-1869. doi: 10.1007/s00134-018-5378-3. Epub 2018 Oct 5.
8
Acute respiratory distress syndrome subphenotypes and differential response to simvastatin: secondary analysis of a randomised controlled trial.急性呼吸窘迫综合征亚表型与辛伐他汀反应的差异:一项随机对照试验的二次分析。
Lancet Respir Med. 2018 Sep;6(9):691-698. doi: 10.1016/S2213-2600(18)30177-2. Epub 2018 Aug 2.
9
Clinical phenotypes of delirium during critical illness and severity of subsequent long-term cognitive impairment: a prospective cohort study.危重病期间谵妄的临床表型与随后长期认知障碍的严重程度:一项前瞻性队列研究。
Lancet Respir Med. 2018 Mar;6(3):213-222. doi: 10.1016/S2213-2600(18)30062-6.
10
The Incremental Burden of Acute Respiratory Distress Syndrome: Long-term Follow-up of a Population-Based Nested Case-Control Study.急性呼吸窘迫综合征的增量负担:基于人群的巢式病例对照研究的长期随访。
Mayo Clin Proc. 2018 Apr;93(4):445-452. doi: 10.1016/j.mayocp.2017.11.025. Epub 2018 Mar 1.